HPP-971

N/A

Report date: 2024/02/05 16:46:30
NME

Base Information

Drug NameHPP-971
Drug Alias NameANT-401HPP-971HPP971
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBTB domain and CNC homolog 1 inhibitorsNuclear factor erythroid 2-related factor 2 activators
TargetsBTB domain and CNC homolog 1Nuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsInflammationNephrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVtv Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAnteris Bio IncVtv Therapeutics Inc
Inactive CompaniesVtv Therapeutics
Active IndicationsNephrosis
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A